Citi maintains Buy on FibroGen (NASDAQ: FGEN) price target of $48.00.Analyst Dr. Joel Beatty sees a 90% approval probability for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE